| Investor | First Light Asset Management, LLC |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by First Light Asset Management, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13G | TLSI / TriSalus Life Sciences, Inc. | 5,374,117 | |||||
| 2026-05-15 | 13G | NPCE / NeuroPace, Inc. | 2,955,423 | |||||
| 2026-05-07 | 13G/A | SIBN / SI-BONE, Inc. | 5,170,568 | 8,120,986 | ||||
| 2026-05-07 | 13G/A | NEO / NeoGenomics, Inc. | 9,784,749 | 14,093,416 | ||||
| 2026-05-07 | 13G/A | AXGN / Axogen, Inc. | 5,940,632 | 3,617,913 | ||||
| 2026-03-13 | 13D/A | HCAT / Health Catalyst, Inc. | 13,922,623 | 13,465,373 | ||||
| 2026-02-17 | 13G/A | MASS / 908 Devices Inc. | 4,680,859 | 6,184,739 | ||||
| 2026-02-17 | 13G/A | ORGO / Organogenesis Holdings Inc. | 8,309,404 | 3,888,816 | ||||
| 2026-02-17 | 13G | PVLA / Palvella Therapeutics, Inc. | 887,031 | |||||
| 2026-02-17 | 13G/A | KRMD / KORU Medical Systems, Inc. | 4,824,354 | 3,831,475 | ||||
| 2026-02-06 | 13G | SLP / Simulations Plus, Inc. | 2,649,879 | |||||
| 2025-12-05 | 13G/A | MASS / 908 Devices Inc. | 3,562,257 | 4,680,859 | ||||
| 2025-12-05 | 13G | SIBN / SI-BONE, Inc. | 589,034 | 5,170,568 | ||||
| 2025-12-03 | 13D | HCAT / Health Catalyst, Inc. | 13,969,217 | 13,922,623 | ||||
| 2025-11-14 | 13G | MASS / 908 Devices Inc. | 3,562,257 | |||||
| 2025-11-14 | 13G/A | ANAB / AnaptysBio, Inc. | 2,265,903 | 864,618 | ||||
| 2025-11-14 | 13G/A | HCAT / Health Catalyst, Inc. | 11,960,250 | 13,969,217 | ||||
| 2025-11-14 | 13G/A | AXGN / Axogen, Inc. | 4,625,680 | 5,940,632 | ||||
| 2025-08-14 | 13G | NEO / NeoGenomics, Inc. | 2,573,891 | 9,784,749 | ||||
| 2025-08-14 | 13G/A | PHLT / Performant Healthcare, Inc. | 11,740,777 | 12,923,915 | ||||
| 2025-08-14 | 13G | ORGO / Organogenesis Holdings Inc. | 8,309,404 | |||||
| 2025-08-07 | 13G/A | ANAB / AnaptysBio, Inc. | 4,653,068 | 2,265,903 | ||||
| 2025-05-13 | 13G/A | HCAT / Health Catalyst, Inc. | 7,148,472 | 11,960,250 | ||||
| 2025-05-07 | 13G/A | KRMD / KORU Medical Systems, Inc. | 4,572,299 | 4,824,354 | ||||
| 2025-03-07 | 13G/A | FNA / Paragon 28, Inc. | 10,589,508 | 1,429,997 | ||||
| 2025-03-07 | 13G | ANAB / AnaptysBio, Inc. | 4,653,068 | |||||
| 2025-02-14 | 13G/A | KRMD / KORU Medical Systems, Inc. | 5,268,411 | 4,572,299 | ||||
| 2025-02-07 | 13G/A | HCAT / Health Catalyst, Inc. | 5,248,421 | 7,148,472 | ||||
| 2025-01-29 | 13G/A | FNA / Paragon 28, Inc. | 10,789,145 | 10,589,508 | ||||
| 2025-01-08 | 13G/A | OPRX / OptimizeRx Corporation | 1,829,074 | 0 | ||||
| 2025-01-08 | 13G/A | AXGN / Axogen, Inc. | 4,364,858 | 4,625,680 | ||||
| 2024-11-14 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 3,678,010 | 1,951,467 | ||||
| 2024-11-14 | 13G | SIBN / SI-BONE, Inc. | 2,552,227 | 589,034 | ||||
| 2024-11-14 | 13G | HCAT / Health Catalyst, Inc. | 5,248,421 | |||||
| 2024-11-14 | 13G/A | SONX / Sonendo, Inc. | 3,641 | |||||
| 2024-11-14 | 13G/A | PHLT / Performant Healthcare, Inc. | 10,321,781 | 11,740,777 | ||||
| 2024-11-07 | 13G | AXGN / Axogen, Inc. | 1,942,270 | 4,364,858 | ||||
| 2024-08-09 | 13G | FNA / Paragon 28, Inc. | 10,789,145 | |||||
| 2024-07-10 | 13G/A | TCMD / Tactile Systems Technology, Inc. | 2,865,547 | 689,815 | ||||
| 2024-06-10 | 13G/A | TELA / TELA Bio, Inc. | 2,723,028 | 0 | ||||
| 2024-06-10 | 13G/A | OPRX / OptimizeRx Corporation | 1,728,430 | 1,829,074 | ||||
| 2024-04-09 | 13D/A | SCTL / Societal CDMO, Inc. | 20,717,614 | 0 | ||||
| 2024-02-14 | 13G | TELA / TELA Bio, Inc. | 2,528,600 | 2,723,028 | ||||
| 2024-02-14 | 13G/A | PHLT / Performant Healthcare, Inc. | 7,789,280 | 10,321,781 | ||||
| 2024-02-14 | 13G/A | SONX / Sonendo, Inc. | 5,073,488 | 5,452,641 | ||||
| 2024-02-14 | 13G | PLRX / Pliant Therapeutics, Inc. | 3,678,010 | |||||
| 2024-02-14 | 13G | SIBN / SI-BONE, Inc. | 2,104,337 | 2,552,227 | ||||
| 2024-02-14 | 13G | OPRX / OptimizeRx Corporation | 1,760,596 | 1,728,430 | ||||
| 2024-02-14 | 13G | KRMD / KORU Medical Systems, Inc. | 6,409,738 | 5,268,411 | ||||
| 2024-02-14 | 13G | TCMD / Tactile Systems Technology, Inc. | 2,863,130 | 2,865,547 | ||||
| 2023-12-07 | 13G | MIRO / Miromatrix Medical Inc | 2,748,272 | |||||
| 2023-11-06 | 13G | TCMD / Tactile Systems Technology, Inc. | 2,863,130 | |||||
| 2023-10-30 | 13G/A | OFIX / Orthofix Medical Inc. | 2,745,449 | 90,833 | ||||
| 2023-10-06 | 13G | TELA / TELA Bio, Inc. | 2,528,600 | |||||
| 2023-08-25 | 13D | SCTL / Societal CDMO, Inc. | 13,587,834 | 20,717,614 | ||||
| 2023-06-09 | 13G | OPRX / OptimizeRx Corporation | 1,760,596 | |||||
| 2023-06-06 | 13G/A | SCTL / Societal CDMO, Inc. | 8,571,870 | 13,587,834 | ||||
| 2023-05-15 | 13G/A | RETA / Reata Pharmaceuticals Inc - Class A | 2,184,846 | 1,319,487 | ||||
| 2023-02-14 | 13G/A | KRMD / KORU Medical Systems, Inc. | 5,917,614 | 6,409,738 | ||||
| 2023-02-14 | 13G/A | OFIX / Orthofix Medical Inc. | 2,745,449 | |||||
| 2023-02-14 | 13G/A | SONX / Sonendo, Inc. | 5,073,488 | |||||
| 2023-02-14 | 13G | SIBN / SI-BONE, Inc. | 2,104,337 | |||||
| 2023-02-14 | 13G/A | RETA / Reata Pharmaceuticals Inc - Class A | 2,184,846 | |||||
| 2023-02-03 | 13G/A | MODN / Model N, Inc. | 2,642,617 | 1,879,678 | ||||
| 2023-02-03 | 13G/A | PHLT / Performant Healthcare, Inc. | 4,922,444 | 7,789,280 | ||||
| 2023-02-03 | 13G | AXGN / Axogen, Inc. | 2,322,382 | 1,942,270 | ||||
| 2023-01-05 | 13G/A | SCTL / Societal CDMO, Inc. | 8,571,870 | |||||
| 2022-05-31 | 13G/A | MEIP / MEI Pharma, Inc. | 11,593,712 | 16,000 | ||||
| 2022-03-01 | 13G | PRTA / Prothena Corporation plc | 2,929,340 | 1,805,038 | ||||
| 2022-02-14 | 13G/A | SPNE / SeaSpine Holdings Corp | 5,506,885 | 7,065,907 | ||||
| 2022-02-14 | 13G/A | MODN / Model N, Inc. | 993,392 | 2,642,617 | ||||
| 2022-02-14 | 13G | AXGN / Axogen, Inc. | 2,352,446 | 2,322,382 | ||||
| 2022-02-14 | 13G/A | PFMT / Performant Healthcare, Inc. | 4,922,444 | |||||
| 2022-02-14 | 13G/A | MEIP / MEI Pharma, Inc. | 11,593,712 | |||||
| 2022-02-14 | 13G/A | KRMD / KORU Medical Systems, Inc. | 5,981,331 | 5,917,614 | ||||
| 2022-02-14 | 13G/A | XENT / Intersect ENT Inc | 1,381,710 | |||||
| 2021-02-16 | 13G | PRTA / Prothena Corporation plc | 2,929,340 | |||||
| 2021-02-16 | 13G | AXGN / Axogen, Inc. | 2,352,446 | |||||
| 2021-02-10 | 13G/A | / Oxford Immunotec Global PLC | 5,046,130 | 95,400 | ||||
| 2021-01-08 | 13G/A | KRMD / KORU Medical Systems, Inc. | 7,335,278 | 5,981,331 | ||||
| 2021-01-08 | 13G/A | SPNE / SeaSpine Holdings Corp | 4,560,163 | 5,506,885 | ||||
| 2021-01-08 | 13G/A | / Oxford Immunotec Global PLC | 4,725,991 | 5,046,130 | ||||
| 2020-05-27 | 13G/A | / Oxford Immunotec Global PLC | 4,167,882 | 4,725,991 | ||||
| 2020-02-14 | 13G/A | / Oxford Immunotec Global PLC | 4,109,515 | 4,167,882 | ||||
| 2020-02-14 | 13G | MODN / Model N, Inc. | 1,726,404 | 993,392 | ||||
| 2020-02-14 | 13G | VAPO / Vapotherm, Inc. | 933,117 | |||||
| 2020-02-14 | 13G | NVTR / Nuvectra Corporation | 1,162,451 | 0 | ||||
| 2020-02-14 | 13G | US29266S3040 / Endologix, Inc. | 2,452,208 | 816,236 | ||||
| 2020-02-14 | 13G/A | SPNE / SeaSpine Holdings Corp | 4,488,944 | 4,560,163 | ||||
| 2020-02-14 | 13G/A | KRMD / KORU Medical Systems, Inc. | 6,848,900 | 7,335,278 | ||||
| 2020-01-09 | 13G/A | SPNE / SeaSpine Holdings Corp | 1,785,071 | 4,488,944 | ||||
| 2019-12-10 | 13G/A | / Oxford Immunotec Global PLC | 2,676,649 | 4,109,515 | ||||
| 2019-07-03 | 13G/A | HBIO / Harvard Bioscience, Inc. | 7,054,771 | 633,333 | ||||
| 2019-04-10 | 13G | US29266S3040 / Endologix, Inc. | 2,452,208 | |||||
| 2019-03-08 | 13G/A | / Oxford Immunotec Global PLC | 2,539,552 | 2,676,649 | ||||
| 2019-02-14 | 13G | NVTR / Nuvectra Corporation | 1,162,451 | |||||
| 2019-02-14 | 13G/A | SPNE / SeaSpine Holdings Corp | 1,586,181 | 1,785,071 | ||||
| 2019-02-14 | 13G/A | / Oxford Immunotec Global PLC | 2,544,918 | 2,539,552 | ||||
| 2019-02-14 | 13G/A | HBIO / Harvard Bioscience, Inc. | 6,496,546 | 7,054,771 | ||||
| 2019-02-14 | 13G | MODN / Model N, Inc. | 1,726,404 | |||||
| 2019-02-14 | 13G/A | STRM / Streamline Health Solutions, Inc. | 1,420,544 | 0 | ||||
| 2019-02-14 | 13G/A | KRMD / KORU Medical Systems, Inc. | 6,800,000 | 6,848,900 | ||||
| 2018-12-21 | 13G | KRMD / KORU Medical Systems, Inc. | 6,800,000 | |||||
| 2018-10-25 | 13G | / Oxford Immunotec Global PLC | 2,544,918 | |||||
| 2018-10-19 | 13G | SPNE / SeaSpine Holdings Corp | 1,586,181 | |||||
| 2018-10-09 | 13G/A | HBIO / Harvard Bioscience, Inc. | 4,638,651 | 6,496,546 | ||||
| 2018-06-11 | 13G/A | TNDM / Tandem Diabetes Care, Inc. | 4,859,238 | 2,271,963 | ||||
| 2018-05-11 | 13G/A | 878193101 / TearLab Corp | 3,564,488 | 0 | ||||
| 2018-02-16 | 13G | TNDM / Tandem Diabetes Care, Inc. | 4,859,238 | |||||
| 2018-02-14 | 13G/A | HBIO / Harvard Bioscience, Inc. | 4,240,289 | 4,638,651 | ||||
| 2018-02-14 | 13G | STRM / Streamline Health Solutions, Inc. | 1,671,475 | 1,420,544 | ||||
| 2017-11-14 | 13G/A | HBIO / Harvard Bioscience, Inc. | 3,572,196 | 4,240,289 | ||||
| 2017-07-07 | 13G | HBIO / Harvard Bioscience, Inc. | 2,744,128 | 3,572,196 | ||||
| 2017-02-15 | 13G | NEO / NeoGenomics, Inc. | 3,089,881 | 2,573,891 | ||||
| 2017-02-15 | 13G | STRM / Streamline Health Solutions, Inc. | 1,631,957 | 1,671,475 | ||||
| 2017-02-15 | 13G | HBIO / Harvard Bioscience, Inc. | 2,039,291 | 2,744,128 | ||||
| 2017-01-11 | 13G | 878193101 / TearLab Corp | 3,564,488 | 3,564,488 | ||||
| 2017-01-10 | 13G | 878193101 / TearLab Corp | 3,564,488 | |||||
| 2016-02-12 | 13G | 878193101 / TearLab Corp | 3,858,047 | 3,969,036 | ||||
| 2016-02-12 | 13G | HBIO / Harvard Bioscience, Inc. | 2,039,291 | |||||
| 2016-02-12 | 13G | NEO / NeoGenomics, Inc. | 3,089,881 | |||||
| 2016-02-12 | 13G | STRM / Streamline Health Solutions, Inc. | 953,232 | 1,631,957 | ||||
| 2015-09-10 | 13G | 878193101 / TearLab Corp | 3,858,047 | |||||
| 2015-06-26 | 13G | STRM / Streamline Health Solutions, Inc. | 953,232 |
